MedCity News
FEBRUARY 4, 2024
Mayo Clinic has entered into a collaboration with TruLite Health — Mayo is helping the Phoenix-based startup develop its software platform designed to address providers’ clinical bias. The health system said it chose to collaborate with TruLite because of the platform’s potential to mitigate health inequities and enhance patient outcomes at the point of care.
Pharmaceutical Commerce
FEBRUARY 4, 2024
Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MedCity News
FEBRUARY 4, 2024
Equitable AI isn’t an aspiration; it’s an absolute necessity, particularly for the millions of older Americans who remain unseen within the current frameworks and miss out on algorithmic benefits such as risk profiles and early interventions for certain diseases.
PharmaTech
FEBRUARY 4, 2024
NICE has recommended the use of AbbVie's Tepkinly as a treatment option for eligible adults with diffuse large B-cell lymphoma.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
MedCity News
FEBRUARY 4, 2024
AI refines KOL (key opinion leader) outreach by quickly uncovering the intricate details of individual thought leaders. AI tools can analyze preferences, behaviors, and interests, equipping MSLs (medical science liaisons) with a comprehensive understanding of each individual KOL.
PharmaTech
FEBRUARY 4, 2024
Webinar Date/Time: Fri, Feb 23, 2024 11:00 AM EST
MedCity News
FEBRUARY 4, 2024
2024 stands at a critical juncture in the battle against soaring pharmacy costs. In 2023, prescription drug costs rose by 8.4%, a 31% increase from the prior year. Stopping this cost escalation requires restructuring the role of pharmacy benefit managers (PBMs) from multiple fronts. On one front, Congress must pass the proposed legislative reforms that can actually curtail opaque PBM practices.
Expert insights. Personalized for you.
131 
Let's personalize your content